Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Chizaram Onyeaghala | Infectious Diseases | Best Researcher Award

Dr. Chizaram Onyeaghala | Infectious Diseases | Best Researcher Award

Consultant Physician | University of Port Harcourt Teaching Hospital | Nigeria

Dr. Chizaram A. Onyeaghala is a Consultant Physician and Infectious Diseases Specialist at the University of Port Harcourt Teaching Hospital, Nigeria. His expertise lies in infectious diseases, HIV medicine, emerging and re-emerging infections, and global health. With a strong academic foundation, he holds qualifications from prestigious institutions, including the West African College of Physicians, the National Postgraduate Medical College of Nigeria, and advanced certifications in Vaccinology, Genomics, and Global Health from Stellenbosch University, Liverpool John Moores University, and the Royal College of Physicians, London. Dr. Onyeaghala’s research portfolio reflects a robust engagement with global health challenges. His works, cited over 837 times with an h-index of 11 and i10-index of 12, have been published in top-tier journals such as The Lancet Infectious Diseases, European Respiratory Journal, and Clinical Infectious Diseases. His collaborations with renowned institutions, including the University of Alabama at Birmingham, Queen Mary University of London, and Washington University in St. Louis, underscore his commitment to international scientific partnership and multidisciplinary inquiry. He has contributed to several landmark studies on Mpox, COVID-19, tuberculosis, antimicrobial resistance, and Lassa fever, which have informed clinical practice and public health response strategies in Nigeria and beyond. As a lead clinician in WHO- and LSTM-funded studies, and a member of national technical working groups, his research and leadership have had tangible societal impact—enhancing epidemic preparedness, infection prevention, and community health resilience. Dr. Onyeaghala’s professional engagements extend to editorial and review roles for international journals and active membership in organizations such as IDSA, IAS, ESCMID, and NIDS. His growing scholarly influence, mentorship activities, and policy-driven research continue to strengthen global infectious disease control and scientific innovation.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Mitjà, O., Alemany, A., Marks, M., Mora, J. I. L., Rodríguez-Aldama, J. C., Silva, M. S. T., Onyeaghala, C. A., et al. (2023). Mpox in people with advanced HIV infection: A global case series. The Lancet, 401(10380), 939–949. https://doi.org/10.1016/S0140-6736(23)00273-3 — Citations: 480

  2. Ogoina, D., Dalhat, M. M., Denue, B. A., Okowa, M., Chika-Igwenyi, N. M., Onyeaghala, C. A., et al. (2023). Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: A cohort study. The Lancet Infectious Diseases, 23(12), 1418–1428. https://doi.org/10.1016/S1473-3099(23)00409-7 — Citations: 49

  3. Global Tuberculosis Network, Casco, N., Jorge, A. L., Palmero, D. J., Alffenaar, J. W., Fox, G. J., Onyeaghala, C. A., et al. (2023). Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. European Respiratory Journal, 62(5). https://doi.org/10.1183/13993003.00925-2023 — Citations: 45

  4. Migliori, G. B., Visca, D., van den Boom, M., Tiberi, S., Silva, D. R., Centis, R., Onyeaghala, C. A., et al. (2021). Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology, 27(3), 248–256. https://doi.org/10.1016/j.pulmoe.2020.12.016 — Citations: 41

  5. Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Onyeaghala, C. A., et al. (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: A systematic analysis for the Global Burden of Disease Study. The Lancet. — Citations: 26

Vishwanath Venketaraman | Infectious Diseases | Best Researcher Award

Prof. Dr. Vishwanath Venketaraman | Infectious Diseases | Best Researcher Award

Professor and Discipline Lead for Microbiology and Immunology | Western University of Health Sciences | United States

Prof. Dr. Vishwanath Venketaraman, Ph.D., is a distinguished microbiologist and immunologist with extensive expertise in tuberculosis, HIV, and host-directed therapies. He earned his Ph.D. in Immunology from the National Institute for Research on Tuberculosis (formerly Tuberculosis Research Center) in 1996, following an M.Sc. in Biology (1991) and B.Sc. in Biology (1989) from the University of Madras. He completed postdoctoral research at the University of Ferrara, Italy, and at leading U.S. institutions including the University of Michigan and Rutgers-New Jersey Medical School. Currently, he serves as Full Professor and Discipline Lead for Microbiology and Immunology at the College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, where he teaches immunology, microbiology, and infectious diseases while mentoring students in preclinical and clinical research. His research program focuses on the host immune response against Mycobacterium tuberculosis, HIV co-infections, and type 2 diabetes, aiming to develop novel adjunctive host-directed therapies for tuberculosis. He has led numerous national and international collaborative projects, authored and edited over 164 publications in top journals and books, and serves as editor and reviewer for multiple reputed journals including Intech, Frontiers in Immunology, MDPI, and Springer Nature. Dr. Venketaraman’s professional service includes chairing research committees, mentoring students, serving on NIH and international grant review panels, and active membership in professional societies such as IEEE and ACM. He has received numerous awards including the Provost’s Distinguished Scholar Award, multiple Outstanding Faculty and Distinguished Teacher Awards, Marquis Who’s Who Lifetime Achievement, and recognition for mentoring over 400 students in research leading to publications. His extensive contributions to infectious disease research, education, and global collaboration underscore his leadership and ongoing impact in biomedical science. With an h-index of 32, 145 documents, and over 2,550 citations, Prof. Venketaraman continues to influence the field of microbiology and immunology at the highest level.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., & Venketaraman, V. (1998). Cytolytic P2X purinoceptors. Cell Death & Differentiation, 5(3), 191–199. Cited by: 349

  2. Shiehzadegan, S., Alaghemand, N., Fox, M., & Venketaraman, V. (2021). Analysis of the delta variant B.1.617.2 COVID-19. Clinics and Practice, 11(4), 778–784. Cited by: 342

  3. To, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020). General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. Journal of Clinical Medicine, 9(8), 2541. Cited by: 267

  4. Teskey, G., Abrahem, R., Cao, R., Gyurjian, K., Islamoglu, H., Lucero, M., … & Venketaraman, V. (2018). Glutathione as a marker for human disease. Advances in Clinical Chemistry, 87, 141–159. Cited by: 253

  5. Zhong, W., Shahbaz, O., Teskey, G., Beever, A., Kachour, N., & Venketaraman, V. (2021). Mechanisms of nausea and vomiting: Current knowledge and recent advances in intracellular emetic signaling systems. International Journal of Molecular Sciences, 22(11), 5797. Cited by: 241

Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

Ms. Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

PHD Scholar at Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Pakistan

Dr. Iram Iqbal, a dedicated pharmacology researcher and academic, has made significant contributions to ethnopharmacology, pharmaceutical quality assurance, and drug development. With a Pharm.D., M.Phil., and ongoing Ph.D. from Bahauddin Zakariya University, her research explores the pharmacological potential of medicinal plants and modern drug delivery mechanisms. She has served in multiple professional roles, including as a Drug Analyst at the Primary & Secondary Healthcare Department and as a lecturer, demonstrating expertise in pharmaceutical instrumentation and quality control aligned with ISO 17025 standards. Dr. Iqbal has published extensively in peer-reviewed journals, contributed book chapters, and presented at numerous national and international conferences. Her technical proficiency with instruments such as HPLC, GC-MS, and FTIR, coupled with her strong communication and organizational skills, underscores her commitment to scientific excellence. Passionate about continuous learning and societal impact, she stands as a strong candidate for the Best Researcher Award, though further international collaborations could enhance her global academic reach.

Professional Profile

Education🎓

Dr. Iram Iqbal has pursued a progressive and research-oriented academic path in the field of pharmacology. She earned her Doctor of Pharmacy (Pharm.D.) degree in 2010 from Bahauddin Zakariya University (BZU), Multan, Pakistan, laying a solid foundation in pharmaceutical sciences. Driven by a passion for research, she completed her M.Phil. in Pharmacology from the same institution in 2015, during which she deepened her understanding of drug mechanisms and medicinal plant pharmacology. Currently, she is enrolled in a Ph.D. program in Pharmacology at BZU, where her research focuses on exploring bioactive compounds in medicinal plants and their therapeutic potentials. Her education has been marked by academic excellence, practical exposure, and a commitment to integrating traditional medicine with modern pharmacological techniques. Throughout her academic journey, Dr. Iqbal has demonstrated a consistent dedication to advancing knowledge in pharmaceutical sciences, positioning herself as a capable researcher and educator in the evolving field of pharmacology.

Professional Experience📝

Dr. Iram Iqbal has accumulated over a decade of professional experience in academia and research, primarily in the field of pharmacology. She began her career as a Lecturer in the Department of Pharmacology at the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, where she has played a vital role in teaching and mentoring pharmacy students. Her professional journey is marked by a strong emphasis on research, particularly in the areas of medicinal plants, pharmacological screening, and drug safety. Dr. Iqbal has been actively involved in supervising undergraduate and postgraduate research projects, contributing to the development of new insights in pharmacology. Her work also includes collaborations on national and international research projects, participation in scientific conferences, and the publication of several research articles in peer-reviewed journals. Her blend of academic teaching and hands-on research experience has established her as a respected professional committed to advancing pharmaceutical education and therapeutic innovation.

Research Interest🔎

Dr. Iram Iqbal’s research interests lie at the intersection of pharmacology, natural product research, and drug safety. She is particularly passionate about exploring the pharmacological properties of medicinal plants and evaluating their therapeutic potential in treating various diseases. Her focus includes the isolation and characterization of bioactive compounds, understanding their mechanisms of action, and assessing their efficacy and toxicity through preclinical studies. Dr. Iqbal is also interested in the pharmacovigilance and safety profiles of both conventional and herbal medicines, aiming to ensure their safe use in clinical practice. Her work often integrates traditional knowledge with modern scientific techniques, promoting evidence-based validation of herbal remedies. She has contributed significantly to the field through her research publications, and her projects often address contemporary health challenges, such as metabolic disorders, inflammation, and infectious diseases. Through her innovative and multidisciplinary approach, Dr. Iqbal seeks to contribute to the development of safer and more effective therapeutic agents.

Award and Honor🏆

Dr. Iram Iqbal has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences and education. Her dedication to academic excellence and impactful research has earned her prestigious accolades at both national and institutional levels. She has been honored with research appreciation certificates and excellence awards from renowned academic bodies and universities. Her scholarly work, particularly in the field of pharmacology and natural product research, has been acknowledged through best paper awards and invitations to present at esteemed scientific conferences. In addition to her research achievements, Dr. Iqbal has been recognized for her exceptional teaching and mentorship, guiding numerous students in their academic and professional journeys. Her commitment to advancing pharmaceutical education and her role in shaping future scientists and researchers have further strengthened her reputation in the academic community. These honors reflect her dedication, integrity, and impact in both research and teaching within the field of pharmacy.

Research Skill🔬

Dr. Iram Iqbal possesses a diverse and robust set of research skills that reflect her expertise in pharmaceutical sciences and pharmacology. She is proficient in designing and conducting both in vitro and in vivo experiments, particularly in the evaluation of natural products for therapeutic use. Her skills include phytochemical screening, drug formulation development, pharmacological activity assessment, and toxicity profiling. Dr. Iqbal is well-versed in utilizing advanced laboratory techniques such as chromatography, spectrophotometry, and microscopy. She also demonstrates strong capabilities in data analysis using statistical software, ensuring accurate interpretation and presentation of research findings. Her ability to conduct systematic literature reviews and synthesize existing knowledge into innovative research proposals highlights her analytical thinking. Moreover, she excels in academic writing, having authored multiple peer-reviewed publications. Her collaborative skills and experience in multidisciplinary research projects further strengthen her ability to contribute meaningfully to scientific advancements in the field of pharmaceutical and biomedical research.

Conclusion💡

Dr. Iram Iqbal possesses a robust academic foundation, diverse research contributions, technical expertise, and a strong national impact, making her highly suitable for the Best Researcher Award. While her portfolio is already compelling, strategic enhancements—particularly in international collaborations, publication strategy, and funding leadership—could further elevate her profile globally.

Publications Top Noted✍️

  • Iqbal, I., Ali, M. A. M., Saqib, F., Alamgir, K., Mubarak, M. S., Chaudhary, A. A., El-Shazly, M., & El-Nashar, H. A. S. (2025). Comprehensive GC-MS profiling and multi-modal pharmacological evaluations of Haloxylon griffithii: In vitro and in vivo approaches. Pharmaceuticals, 18(6), Article 770. https://doi.org/10.3390/ph18060770

    Citation Index: Not available yet (published May 22, 2025; newly released).

  • Iqbal, I., Wilairatana, P., Saqib, F., Nasir, B., Wahid, M., Latif, M. F., Iqbal, A., Naz, R., & Mubarak, M. S. (2023). Plant polyphenols and their potential benefits on cardiovascular health: A review. Molecules, 28(17), 6403. https://doi.org/10.3390/molecules28176403

    Citation Index: According to Crossref, this article has 9 citations as of now.

Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Dr. Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Assistante hospitalo-Universitaire en Hépato Gastroentérologie at Institut superieur des sciences de la sante / universite nazi boni, Burkina faso

Dr. Passolguewindé Delphine ZONGO is a dedicated researcher and lecturer at Université Nazi Boni (UNB) in Burkina Faso, specializing in hepatology and gastroenterology. She holds a Doctorate in Medicine, a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, and a Master’s in Public Health (Nutrition & Public Health). Her research focuses on digestive diseases, liver disorders, and public health challenges prevalent in Africa, including hepatitis, NSAID-induced gastrointestinal conditions, and hepatic steatosis. She has published extensively in high-impact journals and collaborates with international institutions such as Université Pierre et Marie Curie in France. Passionate about medical education and research, she actively mentors young scientists and contributes to healthcare improvements in Burkina Faso. Her expertise, commitment to advancing medical knowledge, and impact on public health make her a notable figure in the medical community and a strong candidate for recognition in research and healthcare leadership.

Professional Profile 

Education

Dr. Passolguewindé Delphine ZONGO has an extensive educational background in medicine, specializing in hepatology and gastroenterology. She earned her Doctorate in Medicine from Université Joseph KI-ZERBO in Burkina Faso, where she developed a strong foundation in clinical practice and medical research. She further pursued a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, enhancing her expertise in digestive and liver diseases. To complement her medical specialization, she obtained a Master’s degree in Public Health with a focus on Nutrition and Public Health, equipping her with the knowledge to address broader healthcare challenges. Her academic journey includes collaborations with prestigious institutions, such as Université Pierre et Marie Curie in France, where she deepened her research skills. Her multidisciplinary education enables her to integrate clinical medicine, research, and public health interventions, making her a leading expert in digestive diseases and a valuable contributor to medical education and healthcare advancement in Burkina Faso.

Professional Experience

Dr. Passolguewindé Delphine ZONGO has built an impressive career in hepatology and gastroenterology, contributing significantly to clinical practice, research, and medical education. She serves as a specialist in hepatology and gastroenterology, diagnosing and treating digestive and liver diseases with a focus on improving patient outcomes. In addition to her clinical work, she is actively involved in medical research, particularly in public health and nutrition, addressing key healthcare challenges in Burkina Faso and beyond. Dr. ZONGO has collaborated with prestigious institutions and contributed to academic publications, reinforcing her expertise in digestive health. She also plays a vital role in medical education, mentoring and training future healthcare professionals. Her experience extends to public health initiatives aimed at raising awareness and improving digestive disease prevention strategies. Through her dedication to patient care, research, and education, Dr. ZONGO continues to make a lasting impact in the medical community, particularly in hepatology and gastroenterology.

Research Interest

Dr. Passolguewindé Delphine ZONGO’s research interests focus on hepatology, gastroenterology, public health, and nutrition, with a particular emphasis on liver diseases and digestive disorders. She is dedicated to studying the epidemiology, diagnosis, and management of liver conditions, including hepatitis, cirrhosis, and metabolic liver diseases. Her work also explores the impact of nutrition on digestive health, aiming to identify dietary factors that influence gastrointestinal diseases. Additionally, Dr. ZONGO is engaged in public health research, addressing healthcare challenges related to digestive diseases in Burkina Faso and other resource-limited settings. She investigates strategies for early detection, prevention, and treatment of gastrointestinal disorders, seeking to improve patient outcomes and healthcare accessibility. Her interdisciplinary approach integrates clinical medicine with public health initiatives, contributing to the development of effective healthcare policies. Through her research, she strives to enhance the understanding of digestive health and promote better disease prevention and management strategies.

Award and Honor

Dr. Passolguewindé Delphine ZONGO has received numerous awards and honors in recognition of her outstanding contributions to hepatology, gastroenterology, and public health research. Her work in liver diseases and digestive health has earned her prestigious accolades from national and international medical organizations. She has been honored for her research on the epidemiology and management of liver conditions in resource-limited settings, receiving grants and fellowships that support her groundbreaking studies. Dr. ZONGO’s commitment to advancing healthcare accessibility and improving patient outcomes has also been acknowledged through various excellence awards in medical research and public health initiatives. She has been invited as a keynote speaker at global conferences, where she shares her expertise with the scientific community. Her dedication to medical education and mentorship has further been recognized with awards for leadership and academic excellence. These honors reflect her significant impact on medical research, education, and healthcare improvement.

Research Skill

Dr. Passolguewindé Delphine ZONGO possesses exceptional research skills, particularly in the fields of hepatology, gastroenterology, and public health. She is highly proficient in designing and conducting epidemiological studies, clinical research, and health data analysis. Her expertise extends to advanced statistical methods, biostatistics, and the application of qualitative and quantitative research techniques to investigate liver diseases and digestive disorders. Dr. ZONGO excels in systematic literature reviews, data interpretation, and evidence-based medical research, enabling her to contribute valuable insights to global healthcare challenges. She has strong skills in grant writing, securing research funding, and collaborating with multidisciplinary teams for large-scale medical studies. Her ability to translate research findings into actionable public health policies demonstrates her commitment to improving healthcare systems. Additionally, she is adept at publishing high-impact research articles and presenting her findings at international conferences, reinforcing her influence as a leading researcher in her field.

Conclusion

Dr. Passolguewindé Delphine ZONGO is a highly qualified candidate for the Best Researcher Award. Her expertise in hepatology, gastroenterology, and public health, along with a strong publication record, makes her a strong contender. To further enhance her competitiveness, she could expand her research leadership, seek more funding, and increase her global collaborations.

Publication Top Noted

Title: Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross-Sectional Study
Authors: D. Napon-Zongo, Delphine; J. Diendéré, Jeoffray; A.M. Sanou, Armel Moumouni; A.N. Zèba, Augustin Nawidimbasba; S. Kouanda, Sèni
Year: 2024
Citations: 0

Solomon Tesfaye | Immunology and Microbiology | Best Researcher Award

Assoc. Prof. Dr. Solomon Tesfaye | Immunology and Microbiology | Best Researcher Award

Researcher at University of Gondar, Ethiopia

Assoc. Prof. Dr. Solomon Tesfaye is a distinguished researcher and academic in the field of biomedical sciences, specializing in infectious diseases, parasitology, and epidemiology. He holds a PhD in Biology from Addis Ababa University and has over two decades of experience in academia, currently serving as an Associate Professor at Gondar University, Ethiopia. His extensive research portfolio includes numerous publications in high-impact journals, focusing on malaria, tuberculosis, hepatitis, HIV, and gastrointestinal parasitic infections. Dr. Tesfaye has made significant contributions to public health through his studies on disease prevalence, risk factors, and control strategies. His work is widely recognized for its impact on healthcare policies and disease management in Ethiopia. In addition to research, he has played a crucial role in mentoring students and advancing scientific knowledge. With a strong academic background, ongoing research, and collaborative efforts, Dr. Tesfaye continues to be a leading figure in biomedical research and higher education.

Professional Profile 

Education

Assoc. Prof. Dr. Solomon Tesfaye has a strong academic background in biology and biomedical sciences. He earned his PhD in Biology under the Biomedical Sciences Stream from Addis Ababa University (2011–2017), where he conducted extensive research on infectious diseases. Prior to that, he completed his Master of Science (M.Sc.) in Biology under the Biomedical Sciences Stream at Addis Ababa University (2006–2008), further strengthening his expertise in medical research. His academic journey began with a Bachelor of Science (B.Sc.) in Biology from Dilla University (1996–2000), providing him with a solid foundation in biological sciences. Dr. Tesfaye’s early education includes high school at Butajira Senior Secondary School (1989–1993) and elementary education at Butajira Elementary School (1982–1988). His progressive academic achievements have enabled him to excel in biomedical research, making significant contributions to infectious disease studies, particularly in Ethiopia. His dedication to education and research has established him as a leading scholar in his field.

Professional Experience

Assoc. Prof. Dr. Solomon Tesfaye has extensive professional experience in academia and research, with a strong focus on biomedical sciences. He is currently an Associate Professor in the Department of Biology at Gondar University, Ethiopia, a position he has held since September 2024. Prior to this, he served as an Assistant Professor at the same university from 2018 to 2024 and as a Lecturer from 2017 to 2018. His teaching career began in 2000, with roles as a Biology and Chemistry teacher in various secondary schools, including Butajira Senior Secondary School and Mechara Secondary School. He also worked at the School of Tomorrow Preparatory Private School in Addis Ababa. Over the years, Dr. Tesfaye has combined his teaching expertise with impactful research in infectious diseases. His vast experience in higher education and research has allowed him to mentor students, contribute to scientific advancements, and enhance public health initiatives in Ethiopia.

Research Interest

Assoc. Prof. Dr. Solomon Tesfaye’s research interests lie in the field of biomedical sciences, with a strong focus on infectious diseases, parasitology, epidemiology, and public health. His work primarily investigates the prevalence, risk factors, and control strategies for diseases such as malaria, tuberculosis, hepatitis, HIV, and gastrointestinal parasitic infections. He is particularly interested in vector-borne diseases and the impact of environmental and biological factors on disease transmission. Dr. Tesfaye’s research also explores antimicrobial resistance patterns, seroprevalence studies, and innovative approaches to disease prevention and management. His studies contribute significantly to understanding disease dynamics in Ethiopia and beyond, with implications for healthcare policies and public health interventions. Through his research, he aims to develop effective strategies for disease control and to bridge the gap between scientific discovery and practical healthcare applications. His commitment to advancing biomedical research continues to have a meaningful impact on both academia and public health.

Award and Honor

There is no specific mention of awards and honors received by Assoc. Prof. Dr. Solomon Tesfaye in the provided information. However, based on his extensive research contributions, academic achievements, and professional experience, he is likely to have earned recognition in his field. As a highly accomplished researcher in biomedical sciences, his work on infectious diseases, parasitology, and epidemiology has had a significant impact on public health in Ethiopia and beyond. His numerous publications in reputable journals, mentorship of students, and dedication to scientific advancement may have led to institutional and academic recognition. Additionally, his role as an Associate Professor at Gondar University and his involvement in collaborative research projects indicate his influence in the academic and scientific community. If further details on specific awards or honors are available, they would provide a clearer picture of his formal recognitions and achievements in the field of biomedical research.

Research Skill

Assoc. Prof. Dr. Solomon Tesfaye possesses strong research skills in biomedical sciences, with expertise in infectious diseases, parasitology, epidemiology, and public health. His ability to design and conduct scientific studies is evident through his extensive publication record in high-impact journals. He excels in data collection, statistical analysis, and interpreting epidemiological trends, particularly in disease prevalence and risk factors. Dr. Tesfaye is skilled in laboratory techniques related to microbiology and parasitology, including serological testing and antimicrobial resistance studies. His research also involves fieldwork, assessing disease patterns, and evaluating environmental influences on disease transmission. He is proficient in using advanced research methodologies, literature reviews, and evidence-based approaches to address public health challenges. His collaboration with multidisciplinary teams and mentoring of students further highlight his research leadership. Through his analytical skills, innovative thinking, and dedication to scientific discovery, Dr. Tesfaye continues to contribute significantly to biomedical research and public health advancements.

Conclusion

Based on his extensive research contributions, impactful publications, and academic experience, Solomon Tesfaye is a strong candidate for the Best Researcher Award. His work significantly contributes to biomedical sciences, particularly in infectious diseases affecting public health. Strengthening international collaborations, securing funding, and translating research into innovations can further enhance his profile.

Publications Top Noted

  • Seroprevalence of Hepatitis B and C and HIV Infections and Associated Risk Factors Among Pregnant Women Attending Antenatal Care Unit at Simada Hospital, South Gondar Zone, Northwest Ethiopia

    • Authors: Solomon Tesfaye, Tirngo Abebaw, Endalkachew Bizualem, Daniel Mehabie, Amir Alelign, Valeria Pasciu
    • Year: 2025
    • Citation: BioMed Research International, DOI: 10.1155/bmri/6895237
  • Prevalence and Associated Risk Factors of Typhoid Fever in Patients Attending Bishoftu Town Health Centers, Oromia, Central Ethiopia

    • Authors: Gebeyehu Mekonnen, Solomon Tesfaye, Damtew Bekele, Esubalew Asmare
    • Year: 2025
    • Citation: Preprint, DOI: 10.21203/rs.3.rs-5875722/v1
  • The Prevalence and Factors Influencing Scabies among Elementary School Children in Yilmana Densa District, Northwest Ethiopia

    • Authors: Solomon Tesfaye, Mequanint Alem, Damtew Bekele, Ashenafi Alemu
    • Year: 2025
    • Citation: Preprint, DOI: 10.21203/rs.3.rs-5850656/v1
  • Sero-Prevalence of Visceral Leishmaniasis and Associated Risk Factors among Febrile Patients Attending Metema Hospital, West Gondar Zone, North West Ethiopia

    • Authors: Solomon Tesfaye, Tibebnesh Getu, Tilahun Yohannes, Damtew Bekele
    • Year: 2024
    • Citation: Acta Parasitologica, DOI: 10.1007/s11686-024-00882-3
  • Sero-prevalence of Visceral Leishmaniasis and Associated Risk Factors among Febrile Patients Attending Metema Hospital, West Gondar Zone, North West Ethiopia

    • Authors: Solomon Tesfaye, Tibebnesh Getu, Tilahun Yohanes, Damtew Bekele
    • Year: 2024
    • Citation: Preprint, DOI: 10.21203/rs.3.rs-4213210/v1
  • Prevalence of Gastrointestinal Parasitic Infections and Associated Risk Factors Among Secondary School Students in Wonji Shoa, Adama District, East Shoa Zone, Oromia Region, Ethiopia

    • Authors: Abera Adugna, Tilahun Yohannes, Solomon Tesfaye, Francesca Mancianti
    • Year: 2024
    • Citation: BioMed Research International, DOI: 10.1155/2024/5520924
  • Seroprevalence of Hepatitis B, C, and its Associated Risk Factors Among Clinically Suspected Patients Attending Poly and Maraki Health Centers, Gondar City, North West Ethiopia

    • Authors: Solomon Tesfaye, Adefework Alemu, Endalkachew Bizualem, Daniel Mehabie, Amir Alelign
    • Year: 2024
    • Citation: SAGE Open Medicine, DOI: 10.1177/20503121241266347
  • Ocular Bacterial Infections and Antibiotic Resistance Patterns in Patients Attending Gondar Teaching Hospital, Northwest Ethiopia

    • Authors: Yeshambel Belyhun, Feleke Moges, Mengistu Endris, Banchamlak Asmare, Bemnet Amare, Damtew Bekele, Solomon Tesfaye, Martha Alemayehu, Fantahun Biadgelegne, Andargachew Mulu et al.
    • Year: 2018
    • Citation: BMC Research Notes, DOI: 10.1186/s13104-018-3705-y
  • Impact of Fertilizers and Green Algae (Spirogyra) on the Survival and Development of Immature Malaria Vector, Anopheles Gambiae Sensu Lato Giles (Diptera: Culicidae)

  • Bacteriological Profile and Drug Susceptibility Patterns in Dacryocystitis Patients Attending Gondar University Teaching Hospital, Northwest Ethiopia

    • Authors: Yared Assefa, Feleke Moges, Mengistu Endris, Banchamlak Zereay, Bemnet Amare, Damtew Bekele, Solomon Tesfaye, Andargachew Mulu, Yeshambel Belyhun
    • Year: 2015
    • Citation: BMC Ophthalmology, DOI: 10.1186/s12886-015-0016-0
  • Trends of Tuberculosis and HIV Infections Between 2004 and 2008 in Wolaita Sodo, Southern Ethiopia

    • Authors: Teklu T, Yeshambel Belyhun, Solomon Tesfaye, Girmay Medhin
    • Year: 2012
    • Citation: Ethiopian Medical Journal, PMID: 22519157
  • Malaria Prevalence Pattern Observed in the Highland Fringe of Butajira, Southern Ethiopia: A Longitudinal Study from Parasitological and Entomological Survey

    • Authors: Solomon Tesfaye, Yeshambel Belyhun, Takele Teklu, Tesfaye Mengesha, Beyene Petros
    • Year: 2011
    • Citation: Malaria Journal, DOI: 10.1186/1475-2875-10-153

Kota Ramana | Immunology and Microbiology | Best Researcher Award

Dr. Kota Ramana | Immunology and Microbiology | Best Researcher Award

Professor at Noorda College of Osteopathic Medicine, United States

Dr. Kota V. Ramana is a Professor in the Department of Biomedical Sciences at Noorda College of Osteopathic Medicine, Provo, UT, USA. He specializes in cellular metabolism, oxidative stress, and inflammation, focusing on the role of aldo-keto reductases in inflammatory pathways. His research aims to understand how cellular metabolites regulate inflammatory responses in various diseases such as diabetes, sepsis, uveitis, asthma, and cancer. Dr. Ramana employs diverse genetic, biochemical, and cell biological techniques to explore the underlying mechanisms of inflammation and develop therapeutic strategies. He has made significant contributions to the understanding of oxidative stress signaling, cell death pathways, and polyol pathway enzymes in inflammatory conditions, with numerous publications in prestigious journals.

Professional Profile 

Education

Dr. Kota V. Ramana holds a Ph.D. in Biochemistry from the Postgraduate Institute of Medical Education and Research in India. His academic foundation laid the groundwork for his research into cellular metabolism and oxidative stress. This rigorous training has enabled him to delve into the biochemical pathways involved in inflammatory diseases, equipping him with a deep understanding of the complex biological systems at play. His educational background continues to shape his approach to studying inflammation and metabolic regulation in disease contexts, forming the basis for his current investigations and innovations in biomedical research.

Professional Experience

Dr. Kota V. Ramana currently serves as a Professor at Noorda College of Osteopathic Medicine, where he leads research on cellular metabolism and inflammation. Over the years, he has gained substantial experience in various aspects of biochemistry, including cell biology and genetic analysis. His work spans multiple inflammatory diseases, aiming to develop novel therapeutic approaches. Additionally, he has contributed to numerous journal articles on oxidative stress, cell signaling, and the role of enzymes in diseases. His academic and research roles have positioned him as a leader in his field, fostering collaborations and advancing scientific understanding of inflammation-related pathologies.

Research Interest

Dr. Kota V. Ramana’s research interests are primarily focused on understanding the molecular mechanisms that govern cellular metabolism, oxidative stress, and inflammation. His work aims to explore the role of aldo-keto reductases in the regulation of inflammatory pathways. He is particularly interested in how cellular metabolites influence signal transduction, cell death, and survival during inflammatory responses. His research addresses a wide range of inflammatory diseases, including diabetes, sepsis, uveitis, asthma, and cancer. By using genetic, biochemical, and cell biological techniques, Dr. Ramana seeks to develop therapeutic strategies that target oxidative stress and metabolic disturbances associated with these pathologies. His interdisciplinary approach to understanding cellular processes at the molecular level holds promise for advancing treatments for inflammatory and metabolic disorders.

Awards and Honors

Dr. Kota V. Ramana has earned recognition for his significant contributions to biomedical research, particularly in the areas of inflammation, oxidative stress, and cellular metabolism. Although specific awards and honors are not detailed, his academic achievements include numerous publications in prestigious peer-reviewed journals, such as the International Journal of Molecular Sciences, Current Molecular Medicine, and Future Medicinal Chemistry. These accolades highlight his excellence in research and his role as a thought leader in his field. His continued efforts to innovate therapeutic strategies for inflammation-related diseases demonstrate his commitment to advancing medical science and improving patient outcomes. Dr. Ramana’s reputation for high-quality research has led to collaborations with leading experts, further solidifying his position as a prominent figure in biochemistry and biomedical sciences.

Publications Top Noted

  1. Therapeutic Significance of NLRP3 Inflammasome in Cancer: Friend or Foe?
    • Authors: Jalali, A.M., Mitchell, K.J., Pompoco, C., Tran, S., Ramana, K.V.
    • Year: 2024
    • Citations: 0
  2. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
    • Authors: Plowman, T.J., Christensen, H., Aiges, M., Shah, M.H., Ramana, K.V.
    • Year: 2024
    • Citations: 5
  3. Significance of Vitamin Supplementation in Reducing the Severity of COVID-19
    • Authors: Aiges, M., Ramana, K.V.
    • Year: 2024
    • Citations: 0
  4. Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications
    • Authors: Plowman, T.J., Shah, M.H., Fernandez, E., Aiges, M., Ramana, K.V.
    • Year: 2023
    • Citations: 7
  5. Therapeutic Potential of Vitamin B1 Derivative Benfotiamine from Diabetes to COVID-19
    • Authors: Allowitz, K.V., Yoo, J.J., Taylor, J.R., Harames, K., Ramana, K.V.
    • Year: 2022
    • Citations: 2
  6. Aldose Reductase Regulates Doxorubicin-Induced Immune and Inflammatory Responses by Activating Mitochondrial Biogenesis
    • Authors: Sonowal, H., Saxena, A., Qiu, S., Srivastava, S., Ramana, K.V.
    • Year: 2021
    • Citations: 13
  7. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
    • Authors: Sonowal, H., Ramana, K.V.
    • Year: 2021
    • Citations: 17
  8. 2′-Hydroxyflavanone Prevents LPS-Induced Inflammatory Response and Cytotoxicity in Murine Macrophages
    • Authors: Sonowal, H., Ramana, K.V.
    • Year: 2020
    • Citations: 8
  9. Didymin by Suppressing NF-κB Activation Prevents VEGF-Induced Angiogenesis in Vitro and In Vivo
    • Authors: Shukla, K., Sonowal, H., Saxena, A., Ramana, K.V.
    • Year: 2019
    • Citations: 20
  10. Erratum: Expression of Concern: Aldose Reductase Mediates the Lipopolysaccharide-Induced Release of Inflammatory Mediators in RAW264.7 Murine Macrophages
  • Authors: Ramana, K.V., Fadl, A.A., Tammali, R., Chopra, A.K., Srivastava, S.K.
  • Year: 2019
  • Citations: 0

Özgür Kurt | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Özgür Kurt | Medicine and Dentistry | Best Researcher Award

M.D. Ph.D. at ACIBADEM UNIVERSITY, Turkey

Prof. Dr. Özgür Kurt is a distinguished Professor of Medical Microbiology at Acibadem University, Turkey, with extensive expertise in parasitology and tropical diseases. He holds both an M.D. and a Ph.D. in Medical Parasitology, and has dedicated over two decades to advancing research and education in the field. His primary research interests focus on parasitic infections, microbiome studies, and the One Health approach. Dr. Kurt has led numerous high-impact research projects related to parasitic diseases, contributing to molecular diagnostic methods, treatment strategies, and the study of disease resistance. He has also been involved in medical education, teaching Medical Parasitology and Tropical Diseases at multiple medical schools in Turkey. In addition to his academic achievements, Dr. Kurt has demonstrated significant community involvement through voluntary healthcare provision in disaster-stricken areas, such as Turkey and Nepal. His contributions to science, education, and humanitarian work make him a leader in his field.

Professional Profile 

Education

Prof. Dr. Özgür Kurt’s academic journey reflects a strong foundation in medicine and parasitology. He completed his medical education at Ege University School of Medicine in Izmir, Turkey, graduating in 1997. Following this, he pursued advanced studies in medical parasitology at Celal Bayar University, where he earned his Ph.D. in 2006. His doctoral research focused on various aspects of parasitic diseases, laying the groundwork for his future research endeavors. Over the years, Dr. Kurt has further expanded his academic qualifications with additional training and professional development in medical microbiology. His commitment to education extends beyond his own studies, as he has taught Medical Parasitology and Tropical Diseases at multiple universities, including Acibadem University. His broad educational background, coupled with his deep specialization in parasitology and tropical diseases, has made him a prominent figure in the academic and scientific communities.

Professional Experience  

Prof. Dr. Özgür Kurt has a distinguished career in both clinical and academic settings. He began his professional journey as a research assistant at Celal Bayar University, where he worked in the Department of Parasitology from 1999 to 2006. He then transitioned to teaching and research roles at the same university, eventually advancing to Assistant and Associate Professor positions in the Department of Biology. In 2013, Dr. Kurt joined Acibadem University School of Medicine, where he became a Professor of Medical Microbiology, specializing in parasitic and tropical diseases. His expertise extends to medical microbiology, where he has been actively involved in both research and education. Dr. Kurt has also worked in clinical laboratory settings, including Acibadem LABMED Clinical Laboratories, and has been a consultant for tropical disease management at Acibadem Hospitals. Additionally, he has led several research projects funded by national and international organizations, focusing on parasitic infections, diagnostic methods, and disease resistance.

Research Interest

Prof. Dr. Özgür Kurt’s research interests focus on parasitic and tropical diseases, with a particular emphasis on their impact in the context of One Health. He explores various aspects of medical parasitology, including the epidemiology, diagnostics, and treatment of parasitic infections. A significant portion of his research involves investigating the role of eukaryotic organisms in the human microbiome, a relatively new and emerging field. Dr. Kurt is particularly interested in tropical diseases such as leishmaniasis, malaria, and amoebiasis, as well as the development of molecular diagnostic methods for detecting these infections. His work also extends to studying the resistance mechanisms of parasites to common treatments, as well as exploring novel therapeutic approaches. Additionally, he leads research projects on the vectors of diseases like leishmaniasis, focusing on the role of mosquitoes and sandflies. His extensive contributions aim to improve disease prevention, diagnosis, and treatment in both clinical and field settings.

Award and Honor

Prof. Dr. Özgür Kurt has received various awards and honors throughout his distinguished career, recognizing his significant contributions to the field of medical microbiology and parasitology. His expertise in tropical diseases and parasitic infections has earned him a reputation as a leading researcher in Turkey and internationally. Dr. Kurt has been acknowledged for his work in developing innovative diagnostic methods and treatments for parasitic diseases. He has received funding for numerous research projects from prestigious organizations, such as TÜBİTAK, and his research has been widely published in respected journals. His commitment to public health and his involvement in humanitarian efforts, including voluntary health care provision during major disasters in Turkey and Nepal, further highlight his dedication to science and society. Dr. Kurt’s ongoing contributions to medical education, clinical practice, and research continue to inspire future generations of scientists and healthcare professionals.

Conclusion

Dr. Özgür Kurt is a highly deserving candidate for the Best Researcher Award. His long-standing contributions to medical microbiology, particularly in parasitic and tropical diseases, have not only advanced scientific understanding but also improved public health outcomes. His academic excellence, leadership in research, and commitment to community service position him as a leader in the field. Strengthening his international collaborations and engaging in interdisciplinary research could further enhance his contributions to global health.

Publications Top Noted
  • Title: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis
    Authors: F Dogruman-Al, H Dagci, H Yoshikawa, Ö Kurt, M Demirel
    Year: 2008
    Citations: 168
  • Title: Molecular epidemiology of Blastocystis infections in Turkey
    Authors: M Özyurt, Ö Kurt, K Mølbak, HV Nielsen, T Haznedaroglu, CR Stensvold
    Year: 2008
    Citations: 165
  • Title: Toxoplasmosis in transplant recipients, Europe, 2010–2014
    Authors: F Robert-Gangneux, V Meroni, D Dupont, F Botterel, JMA Garcia, …
    Year: 2018
    Citations: 134
  • Title: Eradication of Blastocystis in humans: Really necessary for all?
    Authors: Ö Kurt, FD Al, M Tanyüksel
    Year: 2016
    Citations: 102
  • Title: Epidemiological and diagnostic features of Blastocystis infection in symptomatic patients in Izmir province, Turkey
    Authors: H Dagci, K Özgür, M Demirel, A Mandiracioglu, S Aydemir, SAZ Ulas, …
    Year: 2014
    Citations: 101
  • Title: Serological levels of zinc, copper and iron elements among Giardia lamblia infected children in Turkey
    Authors: P Ertan, K Yereli, Ö Kurt, IC BalcioĞlu, A OnaĞ
    Year: 2002
    Citations: 94
  • Title: Rural life, lower socioeconomic status and parasitic infections
    Authors: IC Balcioglu, Ö Kurt, ME Limoncu, G Dinç, M Gümüş, AA Kilimcioglu, …
    Year: 2007
    Citations: 83
  • Title: A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis
    Authors: Ö Kurt, N Girginkardeşler, IC Balcioğlu, A Özbilgin, ÜZ Ok
    Year: 2008
    Citations: 80
  • Title: Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection
    Authors: A Palmeira, E Sousa, A Köseler, R Sabirli, T Gören, I Türkçüer, Ö Kurt, …
    Year: 2020
    Citations: 76
  • Title: Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey
    Authors: A Özbilgin, M Harman, M Karakuş, A Bart, S Töz, Ö Kurt, İ Çavuş, E Polat, …
    Year: 2017
    Citations: 75
  • Title: Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study
    Authors: A Köseler, R Sabirli, T Gören, İ Türkçüer, Ö Kurt
    Year: 2020
    Citations: 69
  • Title: Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions
    Authors: A Özbilgin, G Çulha, S Uzun, M Harman, SG Topal, F Okudan, F Zeyrek, …
    Year: 2016
    Citations: 68